Comment to: "Propofol and survival: an updated meta-analysis of randomized clinical trials": authors' reply
- PMID: 37322553
- PMCID: PMC10273723
- DOI: 10.1186/s13054-023-04528-0
Comment to: "Propofol and survival: an updated meta-analysis of randomized clinical trials": authors' reply
Conflict of interest statement
The authors declare that they have no competing interests.
Comment on
-
Propofol and survival: an updated meta-analysis of randomized clinical trials.Crit Care. 2023 Apr 12;27(1):139. doi: 10.1186/s13054-023-04431-8. Crit Care. 2023. PMID: 37046269 Free PMC article.
References
-
- FDA issues warning on propofol (Diprivan). Can Med Assoc J. 2001;164:1608–1608-a.
-
- Pilia E, Belletti A, Fresilli S, Lee TC, Zangrillo A, Finco G, et al. The effect of heparin full-dose anticoagulation on survival of hospitalized, non-critically Ill COVID-19 patients: a meta-analysis of high quality studies. Lung. 2023;201:135–147. doi: 10.1007/s00408-023-00599-6. - DOI - PMC - PubMed
-
- Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022) [Internet]. Cochrane; 2022. http://www.training.cochrane.org/handbook.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
